Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
AMGN

Amgen

$178.42

0.47 (0.26%)

10:03
05/25/18
05/25
10:03
05/25/18
10:03
Hot Stocks
Amgen's Nplate granted FDA orphan designation »

Amgen's Nplate,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

  • 02

    Jun

Wednesday
AMGN

Amgen

$179.91

1.56 (0.87%)

16:05
05/23/18
05/23
16:05
05/23/18
16:05
Hot Stocks
Amgen announces collaboration to improve cancer treatment symptom management »

Amgen announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

  • 02

    Jun

Monday
AMGN

Amgen

$176.33

0.01 (0.01%)

16:01
05/21/18
05/21
16:01
05/21/18
16:01
Hot Stocks
Amgen: FDA approves Prolia for glucocorticoid-induced osteoporosis »

Amgen announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 28

    May

Over a week ago
NVS

Novartis

$77.15

-0.45 (-0.58%)

, AMGN

Amgen

$174.63

0.9 (0.52%)

08:55
05/18/18
05/18
08:55
05/18/18
08:55
Conference/Events
Amgen to host a webcast »

Amgen's EVP Hooper,…

NVS

Novartis

$77.15

-0.45 (-0.58%)

AMGN

Amgen

$174.63

0.9 (0.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    May

  • 21

    May

  • 22

    May

  • 28

    May

  • 05

    Jun

AMGN

Amgen

08:46
05/18/18
05/18
08:46
05/18/18
08:46
Recommendations
Amgen analyst commentary at Jefferies »

Amgen price for Aimovig…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    May

  • 22

    May

  • 28

    May

NVS

Novartis

$77.15

-0.45 (-0.58%)

, AMGN

Amgen

$174.63

0.9 (0.52%)

08:13
05/18/18
05/18
08:13
05/18/18
08:13
Conference/Events
Amgen to host a webcast »

Amgen's EVP Hooper,…

NVS

Novartis

$77.15

-0.45 (-0.58%)

AMGN

Amgen

$174.63

0.9 (0.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

  • 22

    May

  • 28

    May

  • 05

    Jun

TEVA

Teva

$21.11

0.22 (1.05%)

, AMGN

Amgen

$174.63

0.9 (0.52%)

07:26
05/18/18
05/18
07:26
05/18/18
07:26
Recommendations
Teva, Amgen analyst commentary at Cantor Fitzgerald »

Amgen approval in…

TEVA

Teva

$21.11

0.22 (1.05%)

AMGN

Amgen

$174.63

0.9 (0.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    May

  • 22

    May

  • 28

    May

  • 05

    Jun

  • 16

    Jun

AMGN

Amgen

$174.63

0.9 (0.52%)

, NVS

Novartis

$77.15

-0.45 (-0.58%)

05:25
05/18/18
05/18
05:25
05/18/18
05:25
Recommendations
Amgen, Novartis, Teva, Allergan analyst commentary at Wells Fargo »

Amgen migraine drug price…

AMGN

Amgen

$174.63

0.9 (0.52%)

NVS

Novartis

$77.15

-0.45 (-0.58%)

TEVA

Teva

$21.11

0.22 (1.05%)

AGN

Allergan

$160.29

5.83 (3.77%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    May

  • 21

    May

  • 22

    May

  • 28

    May

  • 05

    Jun

  • 16

    Jun

AMGN

Amgen

$174.63

0.9 (0.52%)

, NVS

Novartis

$77.15

-0.45 (-0.58%)

20:54
05/17/18
05/17
20:54
05/17/18
20:54
Recommendations
Amgen, Novartis analyst commentary at Piper Jaffray »

Amgen's Aimovig…

AMGN

Amgen

$174.63

0.9 (0.52%)

NVS

Novartis

$77.15

-0.45 (-0.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    May

  • 21

    May

  • 22

    May

  • 28

    May

  • 05

    Jun

AMGN

Amgen

$174.63

0.9 (0.52%)

, NVS

Novartis

$77.15

-0.45 (-0.58%)

19:08
05/17/18
05/17
19:08
05/17/18
19:08
Hot Stocks
Amgen's Aimovig priced at $575 per month or $6,900 annually »

Amgen further states:…

AMGN

Amgen

$174.63

0.9 (0.52%)

NVS

Novartis

$77.15

-0.45 (-0.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    May

  • 21

    May

  • 22

    May

  • 28

    May

  • 05

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.